What Blue Bird Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 3 |
| Sells | 1 | 7 |
| Total trades | 2 | 40 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 40 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sanfrey Jeffrey Scott | Chief Operating Officer | Sep 16 | Open-market sale · S | −4,000 | $62.40 | −$250K | 35,011 |
| Thau Daniel Mark | Director | Aug 12 | Open-market buy · P | +350 | $64.37 | +$22.5K | 9,046 |
| Thau Daniel Mark | Director | May 19 | Open-market buy · P | +300 | $65.09 | +$19.5K | 8,696 |
| Grimm Douglas J. | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 28,764 |
| Girardin Steve | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 2,297 |
| Girardin Steve | Director | Apr 01 | Grant / award · A | +1 | — | — | 1 |
| Thau Daniel Mark | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 8,396 |
| Newman Simon J | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 10,334 |
| Hightower Edward T. | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 6,396 |
| Penn Kevin S. | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 6,396 |
| Fream Julie A | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 9,705 |
| Blaufuss Mark | Director | Apr 01 | Grant / award · A | +2,297 | — | — | 10,334 |
| Sanfrey Jeffrey Scott | Chief Operating Officer | Mar 04 | Open-market sale · S | −5,192 | $58.54 | −$304K | 39,011 |
| Sanfrey Jeffrey Scott | Chief Operating Officer | Mar 04 | Exercise / conversion · M | +5,192 | $12.35 | +$64.1K | 44,203 |
| Radulescu Razvan | Chief Financial Officer | Feb 19 | Open-market sale · S | −3,925 | $60.98 | −$239K | 42,255 |
| Radulescu Razvan | Chief Financial Officer | Dec 17 | Disclosed 10b5-1 sale · S | −7,006 | $51.58 | −$361K | 46,180 |
| Radulescu Razvan | Chief Financial Officer | Dec 17 | Exercise / conversion · M | +3,503 | $12.35 | +$43.3K | 53,186 |
| Radulescu Razvan | Chief Financial Officer | Dec 17 | Exercise / conversion · M | +3,503 | $12.35 | +$43.3K | 49,683 |
| Horlock Phil | Director | Dec 12 | Open-market sale · S | −8,341 | $50.35 | −$420K | 225,385 |
| Horlock Phil | Director | Dec 12 | Open-market sale · S | −7,040 | $50.50 | −$356K | 233,726 |
Loading...
